PCOS Is Now PMOS – What the 2026 Global Name Change Means for Women in Ahmedabad
What Changed — PCOS Is Now PMOS
On 12 May 2026, a landmark international consensus paper published in The Lancet officially renamed Polycystic Ovary Syndrome, widely known as PCOS, to Polyendocrine Metabolic Ovarian Syndrome, or PMOS. The announcement was presented at the European Congress of Endocrinology in Prague and represents the outcome of more than a decade of global consultation involving thousands of patients, clinicians, and researchers.
This is genuinely one of the most significant developments in women’s health terminology in recent years, and it is understandably generating a great deal of discussion among patients who have lived with a PCOS diagnosis, sometimes for many years, and are now encountering an unfamiliar new name for the same underlying condition.
Why the Name Was Changed
The core problem with the name Polycystic Ovary Syndrome was that it centred attention on ovarian cysts, when in reality, many people with the condition do not have cysts on their ovaries at all, and the presence of cysts is not what actually drives the condition’s most significant long-term health effects. This mismatch between the name and the underlying biology has, for decades, contributed to confusion among patients, delayed diagnosis, and a narrower clinical focus than the condition genuinely warrants.
The renaming process found strong support for change among both patients and clinicians, reflecting broad recognition that the previous name contributed to stigma, confusion, and fragmented care that did not adequately address the metabolic and hormonal dimensions of the condition. The word ovarian was deliberately retained in the new name, since the ovaries remain genuinely central to the condition, particularly with regard to follicle development and ovulation, but the new terminology now explicitly captures the broader endocrine and metabolic picture that a cyst-focused name never did.
What Polyendocrine Metabolic Ovarian Syndrome Actually Means
Each part of the new name has been chosen specifically to reflect a distinct aspect of the condition:
| Part of the Name | What It Reflects |
|---|---|
| Polyendocrine | The condition involves multiple hormonal systems, not a single hormone or gland in isolation, including elevated androgens and disrupted ovulatory hormone signalling |
| Metabolic | Insulin resistance, elevated risk of impaired glucose tolerance, and long-term cardiometabolic risk are core, integral features of the condition, not incidental findings |
| Ovarian | The ovaries remain genuinely central, particularly with regard to abnormal follicle development and ovulation, even though ovarian cysts are not the defining feature |
| Syndrome | Correctly reflects that this is a cluster of related features rather than a single, isolated disease with one clear cause |
This more complete naming is intended to shift how both clinicians and patients think about the condition, moving attention toward the interconnected hormonal and metabolic drivers, including insulin resistance and androgen excess, rather than narrowly focusing on ovarian appearance on an ultrasound scan.
What Stays the Same for Existing Patients
For anyone who has already been diagnosed with PCOS, it is important to understand clearly what this name change does, and does not, mean for your existing care.
If you have been diagnosed with PCOS, that diagnosis has not been invalidated or changed by the renaming. It simply now falls under updated terminology reflecting the same underlying condition.
The consensus marks an important shift in how experts conceptualise the condition, but it does not immediately alter the diagnostic criteria used in most clinical settings. This remains an area under active ongoing review.
Patients should expect to continue seeing the term PCOS on insurance documentation, medical records, and prescriptions for the foreseeable future, since adoption of new terminology across healthcare systems takes meaningful time.
There is nothing you specifically need to do in response to the name change itself. If you have ongoing concerns about whether your current care adequately addresses metabolic factors such as blood sugar or cardiovascular risk, that is a worthwhile conversation to raise with your gynaecologist regardless of terminology.
Symptoms of PMOS
The clinical presentation of the condition remains the same as what was previously recognised under the name PCOS. What has changed is the framing, with symptoms now more clearly understood as arising from interconnected hormonal and metabolic processes, rather than being viewed primarily through the lens of ovarian cysts.
Infrequent, irregular, or prolonged menstrual cycles resulting from disrupted ovulation, one of the most common presenting features.
Excess androgens, hormones such as testosterone, can cause acne, excess facial or body hair growth known as hirsutism, and scalp hair thinning.
A core metabolic feature present in a large proportion of cases, including in individuals who are not overweight, and linked to longer-term risk of impaired glucose tolerance and type 2 diabetes.
Difficulty managing weight, often linked to underlying insulin resistance, though the condition can affect people across the full range of body weights.
Disrupted ovulation can make conceiving more difficult, though most people with the condition can conceive, often with lifestyle changes, ovulation-inducing medication, or fertility treatment.
Depression, anxiety, and disordered eating patterns are notably more prevalent among people with this condition compared with the general population, reflecting its wide-reaching, whole-body nature.
Why This Change Genuinely Matters for Care
Beyond terminology, this renaming carries real, practical significance for how the condition is diagnosed, researched, and treated going forward. By shifting focus away from a cyst-centric name, the new terminology is intended to push both research and clinical attention toward the metabolic and hormonal roots of the condition, including insulin resistance, androgen excess, and chronic low-grade inflammation, rather than an overly narrow focus on ovarian appearance on ultrasound.
For patients, this shift can translate into more comprehensive care that looks beyond menstrual regularity alone, incorporating meaningful attention to metabolic screening, including blood sugar and cholesterol assessment, and long-term cardiovascular risk, alongside reproductive health management.
Diagnosis and Evaluation in Ahmedabad
While diagnostic criteria remain under active review at a global level, evaluation in clinical practice currently continues to rely on the same well-established approach, generally requiring at least two of the following three features to be present: irregular or absent ovulation, clinical or biochemical signs of elevated androgens, and characteristic ovarian appearance on ultrasound.
| Investigation | What It Assesses |
|---|---|
| Menstrual History | Pattern and regularity of periods, indicating ovulatory function |
| Hormonal Blood Panel | Androgen levels, LH, FSH, and thyroid function to assess hormonal drivers and rule out other causes |
| Fasting Insulin and Glucose | Assesses insulin resistance, a core metabolic feature of the condition |
| Lipid Profile | Cholesterol and triglyceride levels, relevant to long-term cardiovascular risk |
| Pelvic Ultrasound | Assesses ovarian appearance, though this alone does not define the condition |
PMOS Evaluation in Ahmedabad — Excel Hospital
At Excel Hospital, Satellite, Ahmedabad, Dr. Aarti Vazirani provides a comprehensive evaluation that goes beyond menstrual symptoms alone, incorporating hormonal assessment, metabolic screening, and pelvic ultrasound, in keeping with the broader, whole-body understanding reflected in the updated terminology. Patients from across Ahmedabad, including Bopal, Bodakdev, Prahlad Nagar, Vastrapur, and the SG Highway corridor, visit Excel Hospital for this kind of thorough, comprehensive gynaecological care.
Treatment Approach for PMOS
Treatment continues to focus on the same core pillars that have long guided effective management, now framed with a more deliberate emphasis on the condition’s full metabolic and hormonal picture, rather than menstrual symptoms in isolation.
Lifestyle and Metabolic Management
Structured attention to diet, physical activity, and weight management, where relevant, remains foundational, given the central role of insulin resistance in the condition. Even modest, sustained improvements in these areas can produce meaningful improvement in both metabolic and reproductive symptoms.
Hormonal Management
Combined oral contraceptives, anti-androgen medication, and other hormonal approaches remain appropriate options for managing irregular cycles and androgen-related symptoms such as acne or excess hair growth, tailored to individual symptoms and goals.
Insulin-Sensitising Medication
Metformin and related medications continue to play an important role for many patients, particularly where insulin resistance is a significant feature, reflecting the metabolic dimension now explicitly recognised in the condition’s name.
Fertility Support
For those trying to conceive, ovulation-inducing medication and structured fertility support at Excel Hospital’s Infertility Treatment Clinic in Ahmedabad remain effective options, with most patients able to conceive, particularly with early, comprehensive evaluation and support.
Mental Health Support
Given the notably higher prevalence of anxiety, depression, and disordered eating among people with this condition, appropriate mental health screening and support is an increasingly recognised, integral part of comprehensive care, not a separate or optional consideration.
Related Services at Excel Hospital, Satellite, Ahmedabad
Common Myths About the Name Change — Cleared Up for Women in Ahmedabad
| Myth | Fact |
|---|---|
| My PCOS diagnosis is no longer valid now that the name has changed | Your diagnosis remains entirely valid. The renaming reflects updated terminology for the same underlying condition, not a change to your individual diagnosis |
| I need to get retested now that the condition is called something new | No immediate action or retesting is required in response to the name change alone. Diagnostic criteria remain under review, but current evaluation continues as before |
| The treatment for PMOS is completely different from PCOS treatment | The core treatment approach, including lifestyle management, hormonal therapy, insulin-sensitising medication, and fertility support, remains fundamentally the same, now framed with a stronger emphasis on the condition’s metabolic dimension |
| This was a quick, minor rebranding decision | The renaming followed more than a decade of global consultation involving over 22,000 patients and health professionals, making it one of the most thorough disease-renaming processes undertaken in medicine |
| Since ovarian cysts aren’t the main feature, the ovaries don’t matter in this condition | The word ovarian was deliberately retained in the new name because the ovaries remain genuinely central, particularly regarding follicle development and ovulation, even though cysts themselves do not define the condition |
| All doctors and records will use the new name immediately | The global rollout is planned over approximately three years, so you should expect to see PCOS used alongside PMOS in records, prescriptions, and general conversation for some time |
When to See a Gynaecologist in Ahmedabad
| Your Situation | What to Do |
|---|---|
| Diagnosed with PCOS previously, unsure what the name change means for you | Book a follow-up consultation to discuss your current management plan |
| Irregular periods, acne, or excess hair growth not yet evaluated | Book an initial consultation for comprehensive hormonal and metabolic assessment |
| Known PCOS diagnosis, but metabolic health has never been specifically assessed | Request blood sugar and cholesterol screening as part of your ongoing care |
| Trying to conceive with a PCOS or PMOS diagnosis | Request a fertility-focused evaluation, including ovulation assessment |
| Experiencing low mood or anxiety alongside your diagnosis | Raise this directly with your gynaecologist — mental health support is an integral part of comprehensive care |
Dr. Aarti Vazirani provides comprehensive, whole-body care for patients with PCOS and PMOS, addressing hormonal, metabolic, fertility, and mental health dimensions together rather than focusing narrowly on any single symptom. She stays closely engaged with evolving global evidence and guidelines to ensure patients in Ahmedabad receive care that reflects the most current, complete understanding of this common condition. Patients across Ahmedabad, including Satellite, Bopal, Bodakdev, and Vastrapur, trust her clear, thorough approach to this frequently misunderstood condition. Learn more about Dr. Aarti Vazirani
Understand Your Full Picture — Not Just the New Name
Whether you have a longstanding PCOS diagnosis or are exploring symptoms for the first time, a comprehensive evaluation ensures your care addresses the complete hormonal and metabolic picture. Book your consultation at Excel Hospital, Satellite, Ahmedabad today.
Book Your Consultation in AhmedabadFrequently Asked Questions About PCOS Being Renamed PMOS
Medical Disclaimer: This article is written for general health awareness purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. For personal health concerns related to PCOS or PMOS, please consult a qualified gynaecologist. Information accurate as of 2026 based on the global consensus published in The Lancet. Copyright 2026 Excel Hospital, Ahmedabad. All Rights Reserved. www.excelhospitals.com
